Papillary Craniopharyngioma clinical trials

Explore recruiting papillary craniopharyngioma clinical trials.

Recruiting papillary craniopharyngioma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Papillary Craniopharyngioma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Neoadjuvant and postoperative treatment with dabrafenib and trametinib for papillary craniopharyngioma

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Papillary Craniopharyngioma trials by city

Papillary Craniopharyngioma in Toronto Papillary Craniopharyngioma in Vancouver Papillary Craniopharyngioma in Montreal Papillary Craniopharyngioma in Calgary Papillary Craniopharyngioma in Edmonton Papillary Craniopharyngioma in Ottawa Papillary Craniopharyngioma in Winnipeg Papillary Craniopharyngioma in Quebec City Papillary Craniopharyngioma in Hamilton Papillary Craniopharyngioma in Kitchener Papillary Craniopharyngioma in London Papillary Craniopharyngioma in Halifax Papillary Craniopharyngioma in New York Papillary Craniopharyngioma in Los Angeles Papillary Craniopharyngioma in Chicago Papillary Craniopharyngioma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease